Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Clinical trial NCT03786783 · COMPLETED
Trial details
- NCT number
- NCT03786783
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-04
- Primary completion
- 2021-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.